Loading...
Efficacy and safety of darunavir (Prezista(®)) with low-dose ritonavir and other antiretroviral medications in subtype F HIV-1 infected, treatment-experienced subjects in Romania: a post-authorization, open-label, one-cohort, non-interventional, prospective study
INTRODUCTION: The aim of the study was to assess the safety and efficacy of darunavir (Prezista(®)) used in subtype F human immunodeficiency virus – type 1 (HIV-1) infected, antiretroviral therapy (ART)-experienced patients in Romania in routine clinical practice. METHODS: This was a post-authorizat...
Na minha lista:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
National Institute of Infectious Diseases “Prof. Dr. Matei Balş”, Romania, and the European Academy of HIV/AIDS and Infectious Diseases
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4176257/ https://ncbi.nlm.nih.gov/pubmed/25276665 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11599/germs.2014.1057 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|